Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
EASIX-guided risk stratification for complications and outcome after CAR T-cell therapy with ide-cel in relapsed/refractory multiple myeloma.
Frenking JH, Zhou X, Wagner V, Hielscher T, Kauer J, Mai EK, Friedrich MJ, Michel CS, Hajiyianni M, Breitkreutz I, Costello P, Nadeem O, Weinhold N, Goldschmidt H, Schmitt A, Luft T, Schmitt M, Müller-Tidow C, Topp M, Einsele H, Dreger P, Munshi NC, Sperling AS, Rasche L, Sauer S, Raab MS. Frenking JH, et al. Among authors: luft t. J Immunother Cancer. 2024 Oct 7;12(10):e009220. doi: 10.1136/jitc-2024-009220. J Immunother Cancer. 2024. PMID: 39379098 Free PMC article.
Submyeloablative total body irradiation-based conditioning and allogeneic stem cell transplantation in high-risk myeloma with early progression after up-front autologous transplantation.
Mai EK, Schmitt T, Radujkovic A, König L, Goldschmidt H, Ho AD, Luft T, Müller-Tidow C, Dreger P, Hegenbart U, Schönland SO. Mai EK, et al. Among authors: luft t. Br J Haematol. 2022 Jan;196(1):244-248. doi: 10.1111/bjh.17779. Epub 2021 Aug 24. Br J Haematol. 2022. PMID: 34431093 No abstract available.
EASIX for prediction of survival in lower-risk myelodysplastic syndromes.
Merz A, Germing U, Kobbe G, Kaivers J, Jauch A, Radujkovic A, Hummel M, Benner A, Merz M, Dreger P, Luft T. Merz A, et al. Among authors: luft t. Blood Cancer J. 2019 Nov 11;9(11):85. doi: 10.1038/s41408-019-0247-z. Blood Cancer J. 2019. PMID: 31712595 Free PMC article. Clinical Trial.
Pre-transplant EASIX and sepsis after allogeneic stem cell transplantation.
Korell F, Schreck N, Müller-Tidow C, Dreger P, Luft T; Taskforce allogeneic Stem Cell Transplantation, University Hospital Heidelberg. Korell F, et al. Among authors: luft t. Intensive Care Med. 2022 Jun;48(6):753-755. doi: 10.1007/s00134-022-06676-3. Epub 2022 Apr 16. Intensive Care Med. 2022. PMID: 35429256 Free PMC article. No abstract available.
Endothelial Activation and Stress Index (EASIX) to predict mortality after allogeneic stem cell transplantation: a prospective study.
Penack O, Luft T, Peczynski C, Benner A, Sica S, Arat M, Itäla-Remes M, Corral LL, Schaap NPM, Karas M, Raida L, Schroeder T, Dreger P, Metafuni E, Ozcelik T, Sandmaier BM, Kordelas L, Moiseev I, Schoemans H, Koenecke C, Basak GW, Peric Z. Penack O, et al. Among authors: luft t. J Immunother Cancer. 2024 Jan 9;12(1):e007635. doi: 10.1136/jitc-2023-007635. J Immunother Cancer. 2024. PMID: 38199608 Free PMC article.
Venetoclax-based salvage therapy as bridge-to-transplant is feasible and effective in patients with relapsed/refractory AML.
Unglaub JM, Schlenk RF, Middeke JM, Krause SW, Kraus S, Einsele H, Kramer M, Zukunft S, Kauer J, Renders S, Katelari E, Schliemann C, Pabst C, Luft T, Dreger P, Röllig C, Bornhäuser M, Müller-Tidow C, Sauer T. Unglaub JM, et al. Among authors: luft t. Blood Adv. 2024 Sep 18:bloodadvances.2024013086. doi: 10.1182/bloodadvances.2024013086. Online ahead of print. Blood Adv. 2024. PMID: 39293081
142 results